Skip navigation
Speakers

Explore the Impact of Copay Accumulators, Maximizers and Drug Pricing Legislation on Patient Affordability

October 2-4, 2019
  • Philadelphia, PA

Matt Botkin
Vice President, Pharmacy Solutions
Medicom Health

Jennifer Burns
Product Manager, Retail Hub Solutions and Patient Access
ConnectiveRx

Andy Buzbee
VP, Business Development
ConnectiveRx

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Jim Clement
Partner, Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Rujul H. Desai
Of Counsel
Covington & Burling LLP

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division,US Attorney’s Office
District of Eastern Pennsylvania

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

Charles Graybow
Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

Luke Greenwalt
Vice President, Market Access Center of Excellence
IQVIA

Mark Hall
CEO
G8Way Payments, LLC

John Herley
Vice President, Business Development
ConnectiveRx

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Liza Khan
Associate
Covington & Burling LLP

Alan Klein
Chief Development Officer
HealthWell Foundation

Julia Laurin
Vice President, Product Management
ConnectiveRx

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy and 340B Consulting Services, Senior Consultant Visante, Inc.

Paul LeVine
VP, Corporate Strategy
TrialCard

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Boldizsar Nagorniuk
Associate Director, Retail Channel
Kaleo

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

Bob Raffo
President & CEO
FirstView

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Carl Schmid
Deputy Executive Director
The AIDS Institute

Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan

Jordan Steadman
Director, Gross to Net and Patient Access
Teva Pharmaceuticals

Ian Tzeng
Managing Director
L.E.K. Consulting

Randy Vogenberg, Ph.D.
Principal, Institute for Integrated Healthcare (IIH);
Board Chair, Employer Provider Interface Council (EPIC)
of the HQF (Hospital Quality Foundation)

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance

Matt Botkin
Vice President, Pharmacy Solutions
Medicom Health

Jennifer Burns
Product Manager, Retail Hub Solutions and Patient Access
ConnectiveRx

Andy Buzbee
VP, Business Development
ConnectiveRx

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Jim Clement
Partner, Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Rujul H. Desai
Of Counsel
Covington & Burling LLP

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division,US Attorney’s Office
District of Eastern Pennsylvania

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

Charles Graybow
Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

Luke Greenwalt
Vice President, Market Access Center of Excellence
IQVIA

Mark Hall
CEO
G8Way Payments, LLC

John Herley
Vice President, Business Development
ConnectiveRx

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Liza Khan
Associate
Covington & Burling LLP

Alan Klein
Chief Development Officer
HealthWell Foundation

Julia Laurin
Vice President, Product Management
ConnectiveRx

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy and 340B Consulting Services, Senior Consultant Visante, Inc.

Paul LeVine
VP, Corporate Strategy
TrialCard

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Boldizsar Nagorniuk
Associate Director, Retail Channel
Kaleo

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

Bob Raffo
President & CEO
FirstView

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Carl Schmid
Deputy Executive Director
The AIDS Institute

Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan

Jordan Steadman
Director, Gross to Net and Patient Access
Teva Pharmaceuticals

Ian Tzeng
Managing Director
L.E.K. Consulting

Randy Vogenberg, Ph.D.
Principal, Institute for Integrated Healthcare (IIH);
Board Chair, Employer Provider Interface Council (EPIC)
of the HQF (Hospital Quality Foundation)

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance